Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival

American Journal of Pathology

Volumn 181, Issue 5, 2012, Pages 1524-1529

  Rosati, Alessandra ^a   Bersani, Samantha ^b   Tavano, Francesca ^c   Dalla Pozza, Elisa ^d   De Marco, Margot ^a   Palmieri, Marta ^d   De Laurenzi, Vincenzo ^a,e   Franco, Renato ^f   Scognamiglio, Giosuè ^f   Palaia, Raffaele ^f   Fontana, Andrea ^c   Di Sebastiano, Pierluigi ^c   Donadelli, Massimo ^d   Dando, Ilaria ^d   Medema, Jan Paul ^g   Dijk, Frederike ^g   Welling, Lieke ^g   Di Mola, Fabio Francesco ^c   Pezzilli, Raffaele ^h   Turco, Maria Caterina ^a   Scarpa, Aldo ^b   more..

^a UNIVERSITY OF SALERNO   (Italy)

^b Hospital and University Trust   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

^h UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BAG 3 PROTEIN; GEMCITABINE; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SURGERY; CANCER SURVIVAL; CELL LINE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; AGED; APOPTOSIS; CELL LINE, TUMOR; DEOXYCYTIDINE; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 84868122918     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.07.016     Document Type: Article

References (23)

1. D.C. Holzman Pancreatic cancer: will incremental advances begin to make a difference? J Natl Cancer Inst 102 2010 1821 1823
2. M. Hidalgo Pancreatic cancer [published correction appears in N Engl J Med 2010, 363:298] N Engl J Med 362 2010 1605 1617
3. K.Y. Bilimoria, D.J. Bentrem, C.Y. Ko, J. Ritchey, A.K. Stewart, D.P. Winchester, M.S. Talamonti Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database Cancer 110 2007 738 744 (Pubitemid 47257648)
4. A. Li, J. King, A. Moro, M.D. Sugi, D.W. Dawson, J. Kaplan, G. Li, X. Lu, R.M. Strieter, M. Burdick, V.L. Go, H.A. Reber, G. Eibl, O.J. Hines Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer Am J Pathol 178 2011 1340 1349
5. F. Zammarchi, M. Morelli, M. Menicagli, C. Di Cristofano, K. Zavaglia, A. Paolucci, D. Campani, P. Aretini, U. Boggi, F. Mosca, A. Cavazzana, L. Cartegni, G. Bevilacqua, C.M. Mazzanti KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma Am J Pathol 178 2011 361 372
6. K. Satoh, S. Hamada, K. Kimura, A. Kanno, M. Hirota, J. Umino, W. Fujibuchi, A. Masamune, N. Tanaka, K. Miura, S. Egawa, F. Motoi, M. Unno, B.K. Vonderhaar, T. Shimosegawa Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells Am J Pathol 172 2008 926 939 (Pubitemid 351519990)
7. Q. Liao, F. Ozawa, H. Friess, A. Zimmermann, S. Takayama, J.C. Reed, J. Kleeff, M.W. Büchler The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines FEBS Lett 503 2001 151 157 (Pubitemid 32763196)
8. A. Rosati, V. Graziano, V. De Laurenzi, M. Pascale, M.C. Turco BAG3: a multifaceted protein that regulates major cell pathways Cell Death Dis 2 2011 e141
9. M. Ammirante, A. Rosati, C. Arra, A. Basile, A. Falco, M. Festa, M. Pascale, M. d'Avenia, L. Marzullo, M.A. Belisario, M. De Marco, A. Barbieri, A. Giudice, G. Chiappetta, E. Vuttariello, M. Monaco, P. Bonelli, G. Salvatore, M. Di Benedetto, S.L. Deshmane, K. Khalili, M.C. Turco, A. Leone IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth Proc Natl Acad Sci USA 107 2010 7497 7502
10. A. Rosati, M. Ammirante, A. Gentilella, A. Basile, M. Festa, M. Pascale, L. Marzullo, M.A. Belisario, A. Tosco, S. Franceschelli, O. Moltedo, G. Pagliuca, R. Lerose, M.C. Turco Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein Int J Biochem Cell Biol 39 2007 1337 1342 (Pubitemid 47031037)
11. G. Chiappetta, M. Ammirante, A. Basile, A. Rosati, M. Festa, M. Monaco, E. Vuttariello, R. Pasquinelli, C. Arra, M. Zerilli, M. Todaro, G. Stassi, L. Pezzullo, A. Gentilella, A. Tosco, M. Pascale, L. Marzullo, M.A. Belisario, M.C. Turco, A. Leone The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand J Clin Endocrinol Metab 92 2007 1159 1163 (Pubitemid 46465696)
12. M.F. Romano, M. Festa, G. Pagliuca, R. Lerose, R. Bisogni, F. Chiurazzi, G. Storti, S. Volpe, S. Venuta, M.C. Turco, A. Leone BAG3 protein controls B-chronic lymphocytic leukemia cell apoptosis Cell Death Differ 10 2003 383 385 (Pubitemid 36582376)
13. M.F. Romano, M. Festa, A. Petrella, A. Rosati, M. Pascale, V. Bisogni R Poggi, E.C. Kohn, S. Venuta, M.C. Turco, A. Leone BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells Cancer Biol Ther 2 2003 508 510
14. M. Festa, L. Del Valle, K. Khalili, R. Franco, G. Scognamiglio, V. Graziano, V. De Laurenzi, M.C. Turco, A. Rosati BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy Am J Pathol 178 2011 2504 2512
15. R. Franco, G. Scognamiglio, V. Salerno, A. Sebastiani, G. Cennamo, P.A. Ascierto, G. Botti, M.C. Turco, A. Rosati Expression of the anti-apoptotic protein BAG3 in human melanomas J Invest Dermatol 132 2012 252 254
16. K.J. Livak, T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408 (Pubitemid 34164012)
17. D. Cosco, A. Bulotta, M. Ventura, C. Celia, T. Calimeri, G. Perri, D. Paolino, N. Costa, P. Neri, P. Tagliaferri, P. Tassone, M. Fresta In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer Cancer Chemother Pharmacol 64 2009 1009 1020
18. A. Khanna, K. Mahalingam, D. Chakrabarti, G. Periyasamy Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells Cell Mol Biol Lett 16 2011 101 113
19. G. van Tienhoven, D.J. Gouma, D.J. Richel Neoadjuvant chemoradiotherapy has a potential role in pancreatic carcinoma Ther Adv Med Oncol 3 2011 27 33
20. Y.D. Bhutia, S.W. Hung, B. Patel, D. Lovin, R. Govindarajan CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells Cancer Res 71 2011 1825 1835
21. T. Arumugam, V. Ramachandran, K.F. Fournier, H. Wang, L. Marquis, J.L. Abbruzzese, G.E. Gallick, C.D. Logsdon, D.J. McConkey, W. Choi Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer Cancer Res 69 2009 5820 5828
22. A. Takahara, S. Koido, M. Ito, E. Nagasaki, Y. Sagawa, T. Iwamoto, H. Komita, T. Ochi, H. Fujiwara, M. Yasukawa, J. Mineno, H. Shiku, S. Nishida, H. Sugiyama, H. Tajiri, S. Homma Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response Cancer Immunol Immunother 60 2011 1289 1297
23. E. Cesaro, G. Montano, A. Rosati, R. Crescitelli, P. Izzo, M.C. Turco, P. Costanzo WT1 protein is a transcriptional activator of the antiapoptotic bag3 gene Leukemia 24 2010 1204 1206